Genotoxic and Functional Consequences of Transplacental Zidovudine Exposure in Fetal Monkey Brain Mitochondria
- 1 June 2000
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 24 (2), 100-105
- https://doi.org/10.1097/00042560-200006010-00003
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophyThe Lancet, 1999
- Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analoguesThe Lancet, 1999
- Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletionJournal of Hepatology, 1999
- Neuromuscular function in HIV infectionAIDS, 1998
- Clinical toxicity of antiretroviral nucleoside analogsAntiviral Research, 1996
- Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virusThe Journal of Pediatrics, 1995
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994
- Human immunodeficiency virus type 1 infections and myopathy: Clicical relevance of zidovudine therapyAnnals of Neurology, 1993
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990
- Zidovudine-associated myopathyAmerican Journal Of Medicine, 1989